Clinical Value of 18F-FDOPA PET/CT With Contrast Enhancement and Without Carbidopa Premedication in Patients with Insulinoma

Thomas Nakuz, Erik Berger, Karem El‐Rabadi, Wolfgang Wadsak, Alexander Haug, Marcus Hacker, Georgios Karanikas

Anticancer Research · 2018 · 15 citations · 12 references

DOIFull text

Open access

Abstract

Based on our data, <sup>18</sup>F-DOPA PET/CT, with contrast enhancement and without carbidopa premedication, as a 'one-stop' diagnostic modality is a viable option for insulinoma detection.

References

12